global health equity

Senior researchers have identified a combination of regulatory bottlenecks, insufficient funding, and lack of infrastructure as primary reasons Nigeria continues to trail behind other countries in conducting clinical trials. They lamented that despite having a high disease burden and a large population, the country remains underrepresented in global health research. The researchers, who spoke exclusively